Related Experiment Video
Updated: May 20, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Minimal change nephrotic syndrome complicated with malignant ascites in a patient with type II diabetes
Taro Sugase1, Tetsu Akimoto, Yoshitaka Iwazu
1Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Japan.
Abstract:
A large number of renal biopsy studies have shown the concurrent presence of non-diabetic renal disease in diabetics. This report describes one such diabetic female patient with nephrotic syndrome due to minimal change glomerular disease who was successfully treated with prednisolone. Despite the remission of her nephrotic syndrome, she had gradual development of malignant ascites, which was finally interpreted to be linked to primary peritoneal carcinoma. It is necessary to bear in mind that malignancies may not only be the underlying etiology for paraneoplastic glomerular injuries, but also can be an independent pathogenic process, regardless of their nephrotic status during the overall management of the patients with ascites.
Related Concept Videos
Nephrotic Syndrome III : Nursing Management
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Diabetic Nephropathy
Type I Diabetes III: Clinical Manifestations
Diabetes Insipidus I: Introduction
